Pharmaceutical Care and Prescription Refill for Type 2 Diabetes Patients in a University Pharmacy
Article Sidebar
Main Article Content
Abstract
Objective: To compare outcomes of the provision of pharmaceutical care and prescription refill at a pharmacy with those of usual services in a hospital. Methods: This research was a quasi-experimental study. Subjects were type 2 diabetic patients receiving care from the outpatient clinic within a 444 bed hospital. The subjects decided by themselves on the group (intervention or control) they wanted to participate in the study. Pharmaceutical care and prescription refilled were conducted in the intervention group (n=59), while patients in the control group (n = 59) received conventional care in the diabetic clinic at the hospital. The study assessed clinical outcomes (HbA1C, BUN, serum creatinine), economic outcomes (drug cost) and humanistic outcomes (quality of life) before and one year after intervention. The study measures quality of life using SF-36. Results: There were 32 subjects left in each group at the end of the study, because some patients preferred going to primary care centers near their accommodations, moved to the other province, or were referred back to the hospital. There were no differences in sex, duration of diabetes, marital status and concomitant diseases between two groups. Age and the educational level were significantly different between two groups. Mean HbA1C of the intervention group was significantly lower than that of control group. Mean BUN was not different between groups but mean serum creatinine was significantly lower in the intervention group. For the quality of life, general health perception of the intervention group was improved and significantly better than that of the control group. Drug cost was less and the number of encounters with pharmacists was more in the intervention group. Conclusion: This study showed that pharmaceutical care and prescription refilled at a pharmacy improve clinical outcomes and quality of life and reduce medication cost in type 2 diabetic patients. Therefore, pharmaceutical care and prescription refilled in the pharmacy should be an alternative health care service for diabetic patients in the near future.
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
/files/idf_atlas_2015_uk_0.pdf.
2. Tonghong A. Annual epidemiological surveillance report 2012. Bangkok: Bureau of Epidemiology, Thailand, 2012.
3. Division of Strategy and Planning, Bureau of Non Communicable Disease. Annual report in 2015. Bangkok: Department of Disease Control, 2016.
4. Bureau of Strategy and Planning, Office of Permanent Secretary of Ministry of Public Health. Database on individual inpatient in universal coverage scheme and civil servants medical benefit scheme. 2013.
5. Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjaer B, Grundberger E, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001;18:63-77.
6. Chen JH, Ou HT, Lin TC, Lai EC, Kao YH. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial. Int J Clin Pharm. 2016;38:88-95.
7. Chung WW, Chua SS, Lai PS, Chan SP. Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes. Patient Prefer Adherence. 2014; 8: 1185-94.
8. Edwards HD, Webb RD, Scheid DC, Britton ML, Armor BL. A pharmacist visit improves diabetes standards in a patient-centered medical home (PCMH). Am J Med Qual. 2012;27:529-34.
9. Kelly C. Implementation and evaluation of a pharmacist-managed diabetes service. J Manag Care Pharm. 2000;6:488-93.
10. Ko JJ, Lu J, Rascati K, Stock EM, Juan J, Suh K, et al. Analysis of glycemic control of a pharmacist-led medication management program in patients with type 2 diabetes. J Manag Care Spec Pharm. 2016;22:32-7.
11. Mourao AO, Ferreira WR, Martins MA, Reis AM, Carrillo MR, Guimaraes AG, et al. Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial. Int J Clin Pharm. 2013; 35: 79-86.
12. Wishah RA, Al-Khawaldeh OA, Albsoul AM. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: randomized controlled trial. Diabetes Metab Syndr. 2015;9:271-6.
13. Xin C, Ge X, Yang X, Lin M, Jiang C, Xia Z. The impact of pharmaceutical care on improving outcomes in patients with type 2 diabetes mellitus from China: a pre- and post-intervention study. Int J Clin Pharm. 2014; 36:963-8.
14. Xin C, Ge X, Zheng L, Huang P. Evaluation of pharmaceutical care in a diabetes ward from China: a pre-and post-intervention study. Int J Clin Pharm. 2016;38:34-40.
15. Rugpao S. Methodology and statistics in clinical research. Chiang Mai, Thailand: The promotion of medical texbook project of the Faculty of Medicine, Chiang Mai University; 1996.
16. Leurmarnkul W, Meetam P. Development of a quality of life questionnaire : SF-36 (Thai version) Thai Journal of Pharmaceutical Science. 2000; 24 : 92-111.
17. Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual. 2000;15:137-42.
